Dosing (225)Ac-DOTATOC in patients with somatostatin-receptor-positive solid tumors: 5-year follow-up of hematological and renal toxicity

PURPOSE: The aim of this retrospective analysis is to estimate the most appropriate single cycle and cumulative doses of (225)Ac-DOTATOC in patients treated for somatostatin-receptor-expressing cancers. METHODS: (225)Ac-DOTATOC was administered to thirty-nine patients with various somatostatin-recep...

Descripción completa

Detalles Bibliográficos
Autores principales: Kratochwil, Clemens, Apostolidis, Leonidas, Rathke, Hendrik, Apostolidis, Christos, Bicu, Felix, Bruchertseifer, Frank, Choyke, Peter L, Haberkorn, Uwe, Giesel, Frederik L, Morgenstern, Alfred
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712294/
https://www.ncbi.nlm.nih.gov/pubmed/34448031
http://dx.doi.org/10.1007/s00259-021-05474-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712294/
https://www.ncbi.nlm.nih.gov/pubmed/34448031
http://dx.doi.org/10.1007/s00259-021-05474-1

Ejemplares similares